来自MSN24 天
Opus Genetics gets FDA Fast Track designation for Phentolamine Ophthalmic Solution
Opus Genetics (IRD) said that the FDA has granted Fast Track designation for Phentolamine Ophthalmic Solution 0.75% as a potential treatment for chronic night driving impairment and debilitating ...
Healio24 天
FDA grants fast track designation to phentolamine ophthalmic solution 0.75%
Enrollment is complete in the VEGA-3 phase 3 clinical trial of phentolamine for presbyopia. The FDA granted fast track designation to phentolamine ophthalmic solution 0.75% to treat significant ...
Nasdaq24 天
Opus Genetics Announces FDA Fast Track, Trial Enrollment Updates For Phentolamine 0.75%
(RTTNews) - Opus Genetics, Inc. (IRD) announced Wednesday that its Phentolamine Ophthalmic Solution 0.75 percent has been granted Fast Track designation by the U.S. FDA. This designation is for ...